Raymond James Downgrades Loxo Oncology (LOXO) to Market Perform Following Acquisition

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/15/2026

1. AMAT
2. SPY
3. GLOB
4. RDDT
5. HTFL
6. SNDK
7. WDAY
8. ADYEN:NA
9. ADYYF
10. DGNX

January 7, 2019 10:47 AM EST
Get Alerts LOXO Hot Sheet
Price: $234.80 --0%

Rating Summary:
    7 Buy, 8 Hold, 0 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE

Raymond James analyst Dane Leone downgraded Loxo Oncology (NASDAQ: LOXO) from Strong Buy to Market Perform.

For an analyst ratings summary and ratings history on Loxo Oncology click here. For more ratings news on Loxo Oncology click here.

Shares of Loxo Oncology closed at $139.87 yesterday.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Downgrades

Related Entities

Raymond James